NOV 28, 2022 10:12 AM PST

Experimental Drug Lowers 'Bad' Cholesterol by 70%

WRITTEN BY: Annie Lennon

An experimental orally-administered drug reduces 'bad cholesterol' in mice by 70%. The corresponding research was published in Cell Reports.

High cholesterol is a high-risk factor for heart disease, the leading cause of death globally. Statins are currently the most common way to treat high cholesterol. After statins, are drugs known as PCSK9 inhibitors. Unlike statins, which are delivered as tablets, PCSK9 can only be administered via injection, greatly limiting their use. 

'Bad cholesterol or low-density lipoprotein (LDL) receptors sit on the surface of multiple cell types and work by removing excess cholesterol from the blood. PCSK9 is a naturally-occurring protein that reduces the number of LDL receptors in the liver. PCSK9 inhibitors prevent PCSK9 from diminishing LDL receptors in the liver, and thus help the body remove cholesterol from the blood, which ultimately reduces overall cholesterol levels. 

In the current study, researchers found a way to reduce PCSK9 activity via a nitric-oxide-derived molecule. They tested the molecule on human cell lines and on mouse models. Of particular note, they tested the molecules on a mouse model of high cholesterol. After eight weeks of treatment, they noted that LDL cholesterol levels fell by 70%. However, high-density lipoprotein (HDL) levels- 'good' cholesterol- also reduced by 25%. 

The researchers noted that nitric oxide's ability to lower cholesterol was unexpected. Nitric oxide has been shown to reduce cardiovascular risk via combined effects on blood vessel function, blood pressure, and markers of diabetes. However, previous research indicated that the compound had little impact on cholesterol.   

While promising, this is still preliminary research, and it remains unknown how the experimental molecules may work in humans to lower cholesterol levels. Nevertheless, the researchers noted that their findings highlight directions for future work. They added that they might also have implications for cancer treatment, as PCSK9 also prevents immune cells from recognizing cancer cells. 

 

Sources: ScienceDirect, Cell Reports

 

About the Author
Other
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
NOV 22, 2022
Drug Discovery & Development
Non-Opioid Drug Moving to Phase 3 of Clinical Trials
Non-Opioid Drug Moving to Phase 3 of Clinical Trials
For a long time, researchers have strived to discover new treatments for pathological pain. One focus has been to find a ...
DEC 02, 2022
Neuroscience
Scientists Identify Distinct Brain Networks Associated with Risk and Resilience in Depression
Scientists Identify Distinct Brain Networks Associated with Risk and Resilience in Depression
A study published in Brain found a link between the location of brain injury to levels of depression in patients followi ...
DEC 16, 2022
Drug Discovery & Development
The Age of mRNA Cancer Vaccines Starts with Melanoma
The Age of mRNA Cancer Vaccines Starts with Melanoma
Earlier this week, pharmaceuticals Merck and Moderna announced “the first demonstration of efficacy” for an ...
JAN 05, 2023
Neuroscience
Fear Memories are Stored in Prefrontal Cortex
Fear Memories are Stored in Prefrontal Cortex
A University of California, Riverside research team examined how the brain processes and stores memories of traumatic ex ...
JAN 06, 2023
Drug Discovery & Development
Shellfish - the new method to prevent unwanted pregnancies
Shellfish - the new method to prevent unwanted pregnancies
A sugar that is created by shellfish may be the next best way to prevent unwanted pregnancies.  According to a 2022 ...
JAN 12, 2023
Drug Discovery & Development
Blood Pressure Drug Could Treat PTSD in Veterans
Blood Pressure Drug Could Treat PTSD in Veterans
A drug used to treat blood pressure and ADHD may be able to mitigate PTSD symptoms. The corresponding study was publishe ...
Loading Comments...